Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Understand approaches to selecting index funds that minimize taxes in retirement and preserve more of your portfolio.
23,872 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
TradingView remains a go-to hub for charting and market research as volatility persists into 2026. This review breaks...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
Dell Technologies rides a surge in AI infrastructure demand, with a raised outlook and a growing AI backlog lifting t...
A high-profile health scare on stage sparked a ripple of financial questions for touring acts and self-employed profe...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...
A fresh AI hardware rally lifts Super Micro Computer while Meta Platforms remains the core beneficiary of AI spend, e...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Meta Platforms rolls out a new AI compute offering for external customers, aiming to outpace cloud giants. The move t...
Fans are feeling the pinch as prices rise for both stadium seats and bar stools. A new survey shows a growing split i...
Autonomous AI agents paying for goods and services could redefine digital commerce. This article examines how Ripple ...